Latest News

Cardiovascular (CV) mortality is now the most common cause of death in men with prostate cancer, even exceeding prostate cancer mortality.1 Several studies have shown androgen deprivation therapy, which is still the cornerstone of treatment for men with hormone-dependent prostate cancer, is associated with an increased risk of cardiovascular disease (CVD).2,3 However, recent evidence suggests it is […]

Among U.S. men, prostate cancer is the second leading cause of cancer-related death.1 Past studies documented decreasing incidence of prostate cancer overall since 2000 but increasing incidence of distant stage prostate cancer (i.e., signifying spread to parts of the body remote from the primary tumor) starting in 2010.2,3 Past studies described disparities in prostate cancer […]

(UroToday.com) In a talk presented in the Oral Presentations session of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Aristotelis Bamias presented a subgroup analysis from the IMvigor130 trial examining the role of atezolizumab plus platinum-based chemotherapy in patients with locally advanced or metastatic urothelial carcinoma, with stratification according to the primary tumor site.

(UroToday.com) In the oral presentations session examining neoadjuvant versus adjuvant strategies in locally advanced bladder cancer at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Maria Ribal led a discussion of adjuvant strategies.

(UroToday.com) In an oral presentation in the session examining Organ Preservation in Challenging Cases at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Moschini, Dr. Choudhury, and Dr. Roupret discussed a case of organ preservation in bladder cancer.

(UroToday.com) In an oral presentation in the session examining Organ Preservation in Challenging Cases at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Andreas Hiester and Dr. Peter Albers led a discussion regarding organ sparing surgery in testicular cancer.

San Francisco, CA (UroToday.com) — An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight group on Nov. 15, 2020. This interim review of the data suggests that the vaccine is safe […]

Primary hyperoxaluria type 1 (PH1) is associated with nephrocalcinosis (NC) and calcium oxalate (CaOx) kidney stones (KS). Populations of urinary extracellular vesicles (EVs) can reflect kidney pathology.

Thermal injuries associated with Holmium laser lithotripsy of the urinary tract are an underestimated problem in stone therapy. Surgical precision relies exclusively on visual target identification when applying laser energy for stone disintegration.

COVID-19 poses a challenge to healthcare systems worldwide. Due to the increasing number of cases, surgeons in urology have also been confronted with SARS-CoV‑2 infections. Thus, there is an urgent need for clinical guidance and recommendations.